Methyl iodide → (Rac)-2-chloro-9-cyclobutyl-5,7-dimethyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one

HRID 2111379ノート

反応式

HRID 2111379 の反応式
[Cl:1][C:2]1[N:3]=[CH:4][C:5]2[NH:11][C:10](=[O:12])[CH:9]([CH3:13])[CH2:8][N:7]([CH:14]3[CH2:17][CH2:16][CH2:15]3)[C:6]=2[N:18]=1.I[CH3:20].[H-].[Na+]>CN(C)C=O>[Cl:1][C:2]1[N:3]=[CH:4][C:5]2[N:11]([CH3:20])[C:10](=[O:12])[CH:9]([CH3:13])[CH2:8][N:7]([CH:14]3[CH2:17][CH2:16][CH2:15]3)[C:6]=2[N:18]=1

参加物

5

実験手順

To a mixture of 0.94 g (0.00352 mole) of (rac)-2-chloro-9-cyclobutyl-7-methyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VI-52), 0.33 mL (0.00529 mole) of iodomethane and 15 mL of N,N-dimethylformamide at 0 degrees, was added 0.21 g (0.00529 mole) of 60% oil dispersion of sodium hydride. The mixture was stirred at 0 degrees for 2 hours and then partitioned between ethyl acetate and water. The aqueous phase was extracted with ethyl acetate. The combined organic phases were washed successively with water and brine, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel chromatography eluting with hexanes-ethyl acetate (100:0-60:40) to give 0.88 g of (rac)-2-chloro-9-cyclobutyl-5,7-dimethyl-5,7,8,9-tetrahydro-pyrimido[4,5-b][1,4]diazepin-6-one (VII-52) as white powder. HRMS (ES+) m/z Calcd for C13H17CLN4O2+H [(M+H)+]: 281.1164. Found: 281.1163.

後処理

  1. custompartitioned between ethyl acetate and water
  2. extractionThe aqueous phase was extracted with ethyl acetate
  3. washThe combined organic phases were washed successively with water and brine
  4. dry with materialdried over anhydrous magnesium sulfate
  5. filtrationfiltered
  6. concentrationconcentrated under reduced pressure
  7. customThe residue was purified by silica gel chromatography
  8. washeluting with hexanes-ethyl acetate (100:0-60:40)

出典と根拠

ORDレコード
ord-971888e1a5374e8fbc0aff9857c37312
出典データセット
uspto-grants-2009_04
特許番号
US07517873B2

反応ノート

読み込み中…